Muthoka Lawrence Mutinga, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis B, Chronic | 3 | 2019 | 410 | 0.310 |
Why?
|
| Sympathetic Nervous System | 3 | 1997 | 519 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2019 | 2150 | 0.150 |
Why?
|
| Peripartum Period | 1 | 2018 | 137 | 0.140 |
Why?
|
| Colon | 1 | 2004 | 1791 | 0.130 |
Why?
|
| Private Practice | 1 | 2016 | 152 | 0.130 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 1351 | 0.120 |
Why?
|
| Colonoscopy | 2 | 2016 | 1395 | 0.120 |
Why?
|
| Desensitization, Immunologic | 1 | 2000 | 557 | 0.120 |
Why?
|
| Pancreatitis | 1 | 2000 | 1081 | 0.110 |
Why?
|
| Postnatal Care | 1 | 2014 | 260 | 0.100 |
Why?
|
| Prenatal Care | 1 | 2019 | 1141 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2004 | 1920 | 0.100 |
Why?
|
| Clinical Competence | 2 | 2018 | 4788 | 0.100 |
Why?
|
| Crohn Disease | 2 | 2004 | 2278 | 0.100 |
Why?
|
| Drug Hypersensitivity | 1 | 2000 | 918 | 0.090 |
Why?
|
| Fungicides, Industrial | 1 | 1990 | 13 | 0.090 |
Why?
|
| Aftercare | 1 | 2016 | 913 | 0.090 |
Why?
|
| Microsomes, Liver | 1 | 1990 | 172 | 0.090 |
Why?
|
| Postpartum Period | 1 | 2016 | 1178 | 0.080 |
Why?
|
| Mixed Function Oxygenases | 1 | 1990 | 265 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 4190 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 1789 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2018 | 3200 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 4014 | 0.060 |
Why?
|
| Cold Temperature | 3 | 1997 | 783 | 0.050 |
Why?
|
| Hospitals | 1 | 2016 | 3881 | 0.050 |
Why?
|
| Gastroenterology | 2 | 2014 | 580 | 0.050 |
Why?
|
| Esophagoscopes | 1 | 2000 | 16 | 0.050 |
Why?
|
| Physicians | 1 | 2018 | 4584 | 0.040 |
Why?
|
| Hypertension | 2 | 1997 | 8536 | 0.040 |
Why?
|
| Massachusetts | 3 | 2018 | 8837 | 0.040 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2000 | 171 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2000 | 398 | 0.040 |
Why?
|
| Tomography | 1 | 2000 | 411 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2005 | 1116 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2000 | 386 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2004 | 876 | 0.040 |
Why?
|
| Telephone | 1 | 2001 | 624 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 2527 | 0.040 |
Why?
|
| Drug Eruptions | 1 | 2000 | 335 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 2000 | 492 | 0.030 |
Why?
|
| Adenomatous Polyps | 1 | 2016 | 109 | 0.030 |
Why?
|
| Pregnancy | 4 | 2019 | 29893 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2016 | 294 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2016 | 365 | 0.030 |
Why?
|
| Liver | 1 | 1990 | 7512 | 0.030 |
Why?
|
| Acute Disease | 2 | 2005 | 7226 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3608 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 1997 | 633 | 0.030 |
Why?
|
| Hepatitis B | 1 | 2018 | 703 | 0.030 |
Why?
|
| Adult | 8 | 2019 | 221120 | 0.030 |
Why?
|
| Female | 13 | 2019 | 392552 | 0.030 |
Why?
|
| Age Factors | 3 | 2019 | 18384 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2019 | 7965 | 0.030 |
Why?
|
| Family Health | 1 | 1997 | 1254 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2001 | 1115 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12052 | 0.020 |
Why?
|
| Logistic Models | 2 | 2016 | 13249 | 0.020 |
Why?
|
| Captan | 1 | 1990 | 4 | 0.020 |
Why?
|
| Cyclohexenes | 1 | 1990 | 15 | 0.020 |
Why?
|
| Phthalimides | 1 | 1990 | 34 | 0.020 |
Why?
|
| Pentobarbital | 1 | 1990 | 153 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1990 | 413 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 1990 | 145 | 0.020 |
Why?
|
| Body Weight | 2 | 1997 | 4618 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12976 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2087 | 0.020 |
Why?
|
| Humans | 15 | 2019 | 761222 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39127 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 1990 | 411 | 0.020 |
Why?
|
| Middle Aged | 6 | 2016 | 220858 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2000 | 10088 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 24022 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 1990 | 602 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2016 | 80675 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22174 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1993 | 1405 | 0.020 |
Why?
|
| Lower Gastrointestinal Tract | 1 | 2005 | 13 | 0.020 |
Why?
|
| Male | 9 | 2016 | 360703 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 3453 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2756 | 0.010 |
Why?
|
| Morbidity | 1 | 2009 | 1751 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15721 | 0.010 |
Why?
|
| Time Factors | 2 | 2001 | 39957 | 0.010 |
Why?
|
| Outpatients | 1 | 2009 | 1598 | 0.010 |
Why?
|
| Hospitalization | 1 | 2000 | 10707 | 0.010 |
Why?
|
| Potassium | 2 | 1994 | 1309 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1994 | 4947 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2016 | 41496 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7400 | 0.010 |
Why?
|
| Sodium | 2 | 1994 | 1589 | 0.010 |
Why?
|
| Aged | 3 | 2016 | 169292 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2000 | 15637 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2014 | 4679 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 3584 | 0.010 |
Why?
|
| United States | 2 | 2019 | 72341 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1997 | 26200 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2016 | 54437 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 8642 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 58952 | 0.010 |
Why?
|
| Sleep | 1 | 1990 | 4759 | 0.010 |
Why?
|
| Rats | 1 | 1990 | 23705 | 0.010 |
Why?
|
| Supine Position | 1 | 1993 | 205 | 0.010 |
Why?
|
| Equipment Design | 1 | 2000 | 3510 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 20118 | 0.010 |
Why?
|
| Risk Factors | 2 | 2009 | 74241 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2000 | 5250 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 59222 | 0.010 |
Why?
|
| Muscles | 1 | 1993 | 1568 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1993 | 6223 | 0.000 |
Why?
|
| Prognosis | 1 | 2005 | 29688 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1994 | 4165 | 0.000 |
Why?
|
| Heart Rate | 1 | 1993 | 4197 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1993 | 8479 | 0.000 |
Why?
|
| Exercise | 1 | 1994 | 5874 | 0.000 |
Why?
|
| Animals | 1 | 1990 | 168089 | 0.000 |
Why?
|